GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Cash, Cash Equivalents, Marketable Securities

YSB (HKSE:09885) Cash, Cash Equivalents, Marketable Securities : HK$2,121 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is YSB Cash, Cash Equivalents, Marketable Securities?

YSB's quarterly cash, cash equivalents, marketable securities increased from Dec. 2023 (HK$2,000.57 Mil) to Jun. 2024 (HK$2,427.92 Mil) but then stayed the same from Jun. 2024 (HK$2,427.92 Mil) to Dec. 2024 (HK$2,121.04 Mil).

YSB's annual cash, cash equivalents, marketable securities declined from Dec. 2022 (HK$2,084.86 Mil) to Dec. 2023 (HK$2,000.57 Mil) but then increased from Dec. 2023 (HK$2,000.57 Mil) to Dec. 2024 (HK$2,121.04 Mil).


YSB Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for YSB's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Cash, Cash Equivalents, Marketable Securities Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Cash, Cash Equivalents, Marketable Securities
653.57 1,396.36 2,084.86 2,000.57 2,121.04

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial 2,084.86 2,151.30 2,000.57 2,427.92 2,121.04

YSB Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


YSB  (HKSE:09885) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


YSB Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of YSB's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


YSB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
N/A
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group's online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.
Executives
Dcm Investment Management Ix, L.p. 2201 Interest of corporation controlled by you
Dcm Investments (de 5), Llc 2101 Beneficial owner
Dcm Ix International Ltd 2201 Interest of corporation controlled by you
Dcm Ix, L.p. 2201 Interest of corporation controlled by you
Zhang Buzhen 2501 Other
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
H Capital V, L.p. 2101 Beneficial owner
Tmf (cayman) Ltd. 2301 Trustee
Miyt Worldwide Limited 2201 Interest of corporation controlled by you
Coleman Iii Charles 2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd. 2201 Interest of corporation controlled by you
Shleifer Scott 2201 Interest of corporation controlled by you
Tiger Global Management, Llc 2102 Investment manager

YSB Headlines

No Headlines